T. Rowe Price Associates’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
32,889
+3,997
| +14% | +$14.7K | ﹤0.01% | 2859 |
|
|
2025
Q1 | $125K | Sell |
28,892
-7
| -0% | -$30 | ﹤0.01% | 2774 |
|
|
2024
Q4 | $93K | Sell |
28,899
-24,540
| -46% | -$79K | ﹤0.01% | 2835 |
|
|
2024
Q3 | $153K | Buy |
53,439
+2,488
| +5% | +$7.12K | ﹤0.01% | 2740 |
|
|
2024
Q2 | $143K | Hold |
50,951
| – | – | ﹤0.01% | 2680 |
|
|
2024
Q1 | $145K | Buy |
50,951
+5,359
| +12% | +$15.3K | ﹤0.01% | 2701 |
|
|
2023
Q4 | $187K | Buy |
45,592
+921
| +2% | +$3.78K | ﹤0.01% | 2564 |
|
|
2023
Q3 | $143K | Buy |
44,671
+785
| +2% | +$2.51K | ﹤0.01% | 2584 |
|
|
2023
Q2 | $146K | Sell |
43,886
-5,480
| -11% | -$18.2K | ﹤0.01% | 2607 |
|
|
2023
Q1 | $106K | Buy |
49,366
+1,891
| +4% | +$4.06K | ﹤0.01% | 2675 |
|
|
2022
Q4 | $128K | Buy |
47,475
+15,602
| +49% | +$42.1K | ﹤0.01% | 2663 |
|
|
2022
Q3 | $104K | Buy |
31,873
+5,052
| +19% | +$16.5K | ﹤0.01% | 2712 |
|
|
2022
Q2 | $131K | Buy |
26,821
+300
| +1% | +$1.47K | ﹤0.01% | 2693 |
|
|
2022
Q1 | $202K | Buy |
26,521
+15,957
| +151% | +$122K | ﹤0.01% | 2702 |
|
|
2021
Q4 | $98K | Sell |
10,564
-800
| -7% | -$7.42K | ﹤0.01% | 2877 |
|
|
2021
Q3 | $162K | Hold |
11,364
| – | – | ﹤0.01% | 2760 |
|
|
2021
Q2 | $189K | Buy |
+11,364
| New | +$189K | ﹤0.01% | 2734 |
|